EGFR and non-small cell lung carcinoma: The prognostic role of SII has been demonstrated in patients with NSCLC, including NSCLC patients with BM harboring EGFR mutations and patients receiving treatment with EGFR-TKIs, and elevated SII values indicated a worse OS [29, 30].